ID   Kitra-SRS
AC   CVCL_YI69
DR   Wikidata; Q94339704
RX   PubMed=31676869;
CC   Population: Japanese.
CC   Doubling time: ~43 hours (PubMed=31676869).
CC   Sequence variation: Gene fusion; HGNC; HGNC:14214; CIC + HGNC; HGNC:50800; DUX4; Name(s)=CIC-DUX4 (PubMed=31676869).
ST   Source(s): PubMed=31676869
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9
ST   D21S11: 29,32.2
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C165663; CIC-DUX4 sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
RX   PubMed=31676869; DOI=10.1038/s41598-019-52143-3; PMCID=PMC6825133;
RA   Nakai S., Yamada S., Outani H., Nakai T., Yasuda N., Mae H., Imura Y.,
RA   Wakamatsu T., Tamiya H., Tanaka T., Hamada K.-i., Tani A., Myoui A.,
RA   Araki N., Ueda T., Yoshikawa H., Takenaka S., Naka N.;
RT   "Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS,
RT   with autocrine IGF-1R activation and metastatic potential to the
RT   lungs.";
RL   Sci. Rep. 9:15812.1-15812.15(2019).
//